Rimas Orentas, Paola Lopomo, William Babbitt, Marc Vigny, Crystal Mackall. ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors.
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2013, 1 (Suppl 1), pp.P27.
⟨10.1186/2051-1426-1-S1-P27⟩.
⟨inserm-00881036⟩